CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 13 Issue: 2, March 2014



Conference Report: 6th Clinical Trials on Alzheimer’s Disease (CTAD) Conference, Nov 14-16, 2013, The Westin San Diego Gaslamp Quarter Hotel, San Diego, CA, USA

Volume:13   Issue: 2
Pp: 187-190
Hari S. Sharma, Aruna Sharma and Stephen D. Skaper
DOI: 10.2174/1871527313999140312150358
Published on: 12 March, 2014



Commentary (Research Highlights: WNT-erizing Against Neuropathic Pain)

Volume:13   Issue: 2
Pp: 191-191
Stephen D. Skaper
DOI: 10.2174/187152731302140407210436
Published on: 07 April, 2014



Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I) free to download

Volume:13   Issue: 2
Pp: 192-196
Mohammad Amjad Kamal
DOI: 10.2174/1871527313999140307101350
Published on: 06 March, 2014

Exploring N1-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment

Volume:13   Issue: 2
Pp: 197-202
Qurrat ul Ain, Nigel H. Greig, Muhammad S. Nawaz, Sajid Rashid and Mohammad A. Kamal
DOI: 10.2174/18715273113126660136
Published on: 18 September, 2013

Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes

Volume:13   Issue: 2
Pp: 203-212
Taoufik Nedjadi, Absarul Haque, Qamre Alam, Siew H. Gan, Adeel G. Chaudhary, Adel M. Abuzenadah, Ghazi A. Damanhouri and Mohammad A. Kamal
DOI: 10.2174/18715273113126660140
Published on: 18 September, 2013

Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus

Volume:13   Issue: 2
Pp: 213-225
Zeenat Mirza, Ashraf Ali, Ghulam Md. Ashraf, Mohammad A. Kamal, Adel M. Abuzenadah, Adeel G. Choudhary, Ghazi A. Damanhouri and Ishfaq A. Sheikh
DOI: 10.2174/18715273113126660144
Published on: 18 September, 2013

Autophagy Dysfunction and its Link to Alzheimer’s Disease and Type II Diabetes Mellitus

Volume:13   Issue: 2
Pp: 226-246
Cornelia M. Wilson, Amandine Magnaudeix, Catherine Yardin and Faraj Terro
DOI: 10.2174/18715273113126660146
Published on: 18 September, 2013

Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach

Volume:13   Issue: 2
Pp: 247-258
Kalamegam Gauthaman, Peter Natesan Pushparaj, Manoharan Rajeshkumar, Kothandaraman Narasimhan, Mohammed Al-Qahtani, Nam Sang Cheung and Jayapal Manikandan
DOI: 10.2174/18715273113126660138
Published on: 18 September, 2013

Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus

Volume:13   Issue: 2
Pp: 259-264
Rizwanul Haque and Aamir Nazir
DOI: 10.2174/18715273113126660139
Published on: 18 September, 2013

A Neuroinformatics Study Describing Molecular Interaction of Cisplatin with Acetylcholinesterase: A Plausible Cause for Anticancer Drug Induced Neurotoxicity

Volume:13   Issue: 2
Pp: 265-270
Mohd Hassan Baig, Syed Mohd. Danish Rizvi, Shazi Shakil, Mohammad Amjad Kamal and Saif Khan
DOI: 10.2174/18715273113126660143
Published on: 18 September, 2013

Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies

Volume:13   Issue: 2
Pp: 271-282
Ying Dai and Mohammad A. Kamal
DOI: 10.2174/18715273113126660134
Published on: 18 September, 2013

Epigenomic Approach in Understanding Alzheimer’s Disease and Type 2 Diabetes Mellitus

Volume:13   Issue: 2
Pp: 283-289
Munvar M. Shaik, Siew H. Gan and Mohammad A. Kamal
DOI: 10.2174/18715273113126660181
Published on: 30 September, 2013

Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects

Volume:13   Issue: 2
Pp: 290-298
Tanveer A. Dar, Ishfaq A. Sheikh, Showkat A. Ganie, Riyasat Ali, Laishram R. Singh, Siew Hua Gan, Mohammad A. Kamal and Mohammad A. Zargar
DOI: 10.2174/18715273113126660135
Published on: 18 September, 2013

Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting

Volume:13   Issue: 2
Pp: 299-304
Nasimudeen R. Jabir, Mohammad A. Kamal, Adel Mohammad Abuzenadah, Siew Hua Gan, Mohammed Nabil Alama, Saleh S. Baeesa and Shams Tabrez
DOI: 10.2174/18715273113126660145
Published on: 18 September, 2013

Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease

Volume:13   Issue: 2
Pp: 305-311
Muhammad I. Naseer, Fehmida Bibi, Mohammed H. Alqahtani, Adeel G. Chaudhary, Esam I. Azhar, Mohammad A. Kamal and Muhammad Yasir
DOI: 10.2174/18715273113126660147
Published on: 18 September, 2013

A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease

Volume:13   Issue: 2
Pp: 312-321
Firoz Ahmed, Juned Asghar Ansari, Zahid Eqbal Ansari, Qamre Alam, Siew Hua Gan, Mohammad A. Kamal and Ejaj Ahmad
DOI: 10.2174/18715273113126660133
Published on: 18 September, 2013

Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation

Volume:13   Issue: 2
Pp: 338-346
Mohammad A. Kamal, Shubha Priyamvada, Arivarasu N. Anbazhagan, Nasimudeen R. Jabir, Shams Tabrez and Nigel H. Greig
DOI: 10.2174/18715273113126660137
Published on: 18 September, 2013

Neuropeptides as Therapeutic Targets to Combat Stress-Associated Behavioral and Neuroendocrinological Effects

Volume:13   Issue: 2
Pp: 347-368
Anjana Bali, Nirmal Singh and Amteshwar Singh Jaggi
DOI: 10.2174/1871527313666140314163920
Published on: 14 March, 2014

The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease

Volume:13   Issue: 2
Pp: 369-373
Hong-Fang Ji and Liang Shen
DOI: 10.2174/18715273113129990077
Published on: 05 July, 2013